MetaCap

Enliven Therapeutics Insider Trades

NASDAQ: ELVNHealth CareBiotechnology: Pharmaceutical PreparationsUSD

40.98+0.35 (+0.86%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
66 · $75.54M
Shares bought / sold
0 / 1.75M
Net activity
Net selling $75.5 million

Enliven Therapeutics insider activity

Over the last 12 months, Enliven Therapeutics insiders reported 89 transactions on SEC Form 4: 0 open-market purchases and 66 sales. Insiders bought $0 and sold $75.5 million worth of stock, for net insider selling of $75.5 million. The largest seller was ORBIMED ADVISORS LLC & OrbiMed Capital GP VII LLC & OrbiMed Genesis GP LLC, with $51.7 million in reported sales.

The most recent filing shows Garland J. Scott (Director) reporting a transaction in 13,000 shares at $15.47 on Oct 1, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put ELVN's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

ELVN insider transactions

Enliven Therapeutics insider transactions
DateInsiderTypeSharesValueFiling
Oct 1, 2026Garland J. ScottDirectorSale13,000$606.72KForm 4
Oct 1, 2026Garland J. ScottDirectorOption exercise13,000$201.11KForm 4
Sep 17, 2026Collins Helen LouiseCHIEF MEDICAL OFFICERSale240$12.36KForm 4
Sep 17, 2026Collins Helen LouiseCHIEF MEDICAL OFFICERSale1,844$93.51KForm 4
Sep 17, 2026Collins Helen LouiseCHIEF MEDICAL OFFICERSale2,916$145.89KForm 4
Sep 17, 2026Collins Helen LouiseCHIEF MEDICAL OFFICEROption exercise5,000$12.40KForm 4
Sep 17, 2026Hohl BenjaminCHIEF FINANCIAL OFFICERSale289$14.88KForm 4
Sep 17, 2026Hohl BenjaminCHIEF FINANCIAL OFFICERSale2,194$111.27KForm 4
Sep 17, 2026Hohl BenjaminCHIEF FINANCIAL OFFICERSale3,535$176.85KForm 4
Sep 17, 2026Hohl BenjaminCHIEF FINANCIAL OFFICEROption exercise3,982$59.13KForm 4
Aug 17, 2026Collins Helen LouiseCHIEF MEDICAL OFFICERSale1,100$65.28KForm 4
Aug 17, 2026Collins Helen LouiseCHIEF MEDICAL OFFICERSale3,900$227.65KForm 4
Aug 17, 2026Collins Helen LouiseCHIEF MEDICAL OFFICEROption exercise5,000$12.40KForm 4
Aug 17, 2026Hohl BenjaminCHIEF FINANCIAL OFFICERSale1,388$82.38KForm 4
Aug 17, 2026Hohl BenjaminCHIEF FINANCIAL OFFICERSale4,630$270.17KForm 4
Aug 4, 2026Derynck Mika KDirectorSale158,795$9.56MForm 4
Aug 4, 2026Derynck Mika KDirectorOption exercise20,491$460.43KForm 4
Aug 4, 2026Derynck Mika KDirectorOption exercise23,364$346.96KForm 4
Aug 4, 2026Derynck Mika KDirectorOption exercise27,567$696.89KForm 4
Aug 4, 2026Derynck Mika KDirectorOption exercise87,373$216.69KForm 4
Jul 17, 2026Collins Helen LouiseCHIEF MEDICAL OFFICERSale63$3.40KForm 4
Jul 17, 2026Collins Helen LouiseCHIEF MEDICAL OFFICERSale2,184$116.67KForm 4
Jul 17, 2026Collins Helen LouiseCHIEF MEDICAL OFFICERSale2,063$108.08KForm 4
Jul 17, 2026Collins Helen LouiseCHIEF MEDICAL OFFICERSale459$23.66KForm 4
Jul 17, 2026Collins Helen LouiseCHIEF MEDICAL OFFICERSale231$11.56KForm 4
Jul 17, 2026Collins Helen LouiseCHIEF MEDICAL OFFICEROption exercise5,000$12.40KForm 4
Jul 17, 2026Hohl BenjaminCHIEF FINANCIAL OFFICERSale123$6.63KForm 4
Jul 17, 2026Hohl BenjaminCHIEF FINANCIAL OFFICERSale2,638$140.82KForm 4
Jul 17, 2026Hohl BenjaminCHIEF FINANCIAL OFFICERSale2,564$134.14KForm 4
Jul 17, 2026Hohl BenjaminCHIEF FINANCIAL OFFICERSale369$19.00KForm 4
Jul 17, 2026Hohl BenjaminCHIEF FINANCIAL OFFICERSale324$16.19KForm 4
Jul 17, 2026Hohl BenjaminCHIEF FINANCIAL OFFICEROption exercise1,072$2.66KForm 4
Jul 6, 2026Kunkel Lori AnneDirectorSale5,889$299.42KForm 4
Jul 6, 2026Kunkel Lori AnneDirectorSale4,111$205.48KForm 4
Jun 22, 2026ORBIMED ADVISORS LLC & OrbiMed Capital GP VII LLC & OrbiMed Genesis GP LLC10% OwnerSale46,776$2.10MForm 4
Jun 22, 2026ORBIMED ADVISORS LLC & OrbiMed Capital GP VII LLC & OrbiMed Genesis GP LLC10% OwnerSale787,024$35.72MForm 4
Jun 22, 2026ORBIMED ADVISORS LLC & OrbiMed Capital GP VII LLC & OrbiMed Genesis GP LLC10% OwnerSale1,477$66.47KForm 4
Jun 22, 2026ORBIMED ADVISORS LLC & OrbiMed Capital GP VII LLC & OrbiMed Genesis GP LLC10% OwnerSale24,846$1.13MForm 4
Jun 17, 2026Collins Helen LouiseCHIEF MEDICAL OFFICERSale1,133$50.69KForm 4
Jun 17, 2026Collins Helen LouiseCHIEF MEDICAL OFFICERSale2,599$114.02KForm 4
Jun 17, 2026Collins Helen LouiseCHIEF MEDICAL OFFICERSale1,268$54.30KForm 4
Jun 17, 2026Collins Helen LouiseCHIEF MEDICAL OFFICEROption exercise5,000$12.40KForm 4
Jun 17, 2026Hohl BenjaminCHIEF FINANCIAL OFFICERSale1,238$55.40KForm 4
Jun 17, 2026Hohl BenjaminCHIEF FINANCIAL OFFICERSale3,401$149.18KForm 4
Jun 17, 2026Hohl BenjaminCHIEF FINANCIAL OFFICERSale1,379$59.00KForm 4
Jun 17, 2026Hohl BenjaminCHIEF FINANCIAL OFFICEROption exercise6,018$14.92KForm 4
Jun 15, 2026ORBIMED ADVISORS LLC & OrbiMed Capital GP VII LLC & OrbiMed Genesis GP LLC10% OwnerSale272,322$12.26MForm 4
Jun 15, 2026ORBIMED ADVISORS LLC & OrbiMed Capital GP VII LLC & OrbiMed Genesis GP LLC10% OwnerSale9,086$409.05KForm 4
Jun 5, 2026Kunkel Lori AnneDirectorSale354$12.68KForm 4
Jun 5, 2026Kunkel Lori AnneDirectorSale1,867$66.01KForm 4
Jun 5, 2026Kunkel Lori AnneDirectorSale7,779$266.66KForm 4
May 18, 2026Collins Helen LouiseCHIEF MEDICAL OFFICERSale223$9.19KForm 4
May 18, 2026Collins Helen LouiseCHIEF MEDICAL OFFICERSale1,302$52.40KForm 4
May 18, 2026Collins Helen LouiseCHIEF MEDICAL OFFICERSale3,475$137.38KForm 4
May 18, 2026Collins Helen LouiseCHIEF MEDICAL OFFICEROption exercise5,000$12.40KForm 4
Apr 17, 2026Collins Helen LouiseCHIEF MEDICAL OFFICERSale2,441$117.30KForm 4
Apr 17, 2026Collins Helen LouiseCHIEF MEDICAL OFFICERSale2,419$114.64KForm 4
Apr 17, 2026Collins Helen LouiseCHIEF MEDICAL OFFICERSale140$6.41KForm 4
Apr 17, 2026Collins Helen LouiseCHIEF MEDICAL OFFICEROption exercise5,000$12.40KForm 4
Mar 25, 2026Collins Helen LouiseCHIEF MEDICAL OFFICERSale40,000$1.40MForm 4
Mar 25, 2026Collins Helen LouiseCHIEF MEDICAL OFFICEROption exercise40,000$99.20KForm 4
Mar 17, 2026Collins Helen LouiseCHIEF MEDICAL OFFICERSale5,000$138.80KForm 4
Mar 17, 2026Collins Helen LouiseCHIEF MEDICAL OFFICEROption exercise5,000$12.40KForm 4
Mar 10, 2026Collins Helen LouiseCHIEF MEDICAL OFFICERSale10,129$305.83KForm 4
Mar 10, 2026Collins Helen LouiseCHIEF MEDICAL OFFICEROption exercise10,129$25.12KForm 4
Mar 9, 2026Collins Helen LouiseCHIEF MEDICAL OFFICERSale29,871$896.81KForm 4
Mar 9, 2026Collins Helen LouiseCHIEF MEDICAL OFFICEROption exercise29,871$74.08KForm 4
Mar 6, 2026Hohl BenjaminCHIEF FINANCIAL OFFICERSale10,000$295.84KForm 4
Feb 17, 2026Heyman Richard A.DirectorSale1,230$32.20KForm 4
Feb 17, 2026Collins Helen LouiseCHIEF MEDICAL OFFICERSale45,000$1.18MForm 4
Feb 17, 2026Collins Helen LouiseCHIEF MEDICAL OFFICEROption exercise45,000$111.60KForm 4
Feb 12, 2026Collins Helen LouiseCHIEF MEDICAL OFFICERAward25,000—Form 4
Feb 12, 2026Hohl BenjaminCHIEF FINANCIAL OFFICERAward25,000—Form 4
Feb 12, 2026Lyssikatos Joseph PCHIEF SCIENTIFIC OFFICERAward18,750—Form 4
Feb 12, 2026Patel AnishCHIEF OPERATING OFFICERAward20,000—Form 4
Feb 6, 2026Lyssikatos Joseph PCHIEF SCIENTIFIC OFFICERSale5,000$145.22KForm 4
Jan 20, 2026Heyman Richard A.DirectorSale718$19.35KForm 4
Jan 20, 2026Heyman Richard A.DirectorSale512$13.55KForm 4
Jan 20, 2026Lyssikatos Joseph PCHIEF SCIENTIFIC OFFICERSale14,509$390.28KForm 4
Jan 20, 2026Lyssikatos Joseph PCHIEF SCIENTIFIC OFFICERSale5,491$144.81KForm 4
Jan 9, 2026Heyman Richard A.DirectorSale4,285$107.13KForm 4
Jan 9, 2026Lyssikatos Joseph PCHIEF SCIENTIFIC OFFICERSale50,000$1.46MForm 4
Jan 9, 2026Lyssikatos Joseph PCHIEF SCIENTIFIC OFFICERSale41,198$1.03MForm 4
Jan 9, 2026Patel AnishCHIEF OPERATING OFFICERSale243$6.93KForm 4
Jan 9, 2026Patel AnishCHIEF OPERATING OFFICERSale48,057$1.34MForm 4
Jan 8, 2026Heyman Richard A.DirectorSale8,015$200.66KForm 4
Jan 8, 2026Heyman Richard A.DirectorSale1,620$40.50KForm 4
Jan 8, 2026Lyssikatos Joseph PCHIEF SCIENTIFIC OFFICERSale33,802$842.47KForm 4
Jan 8, 2026Lyssikatos Joseph PCHIEF SCIENTIFIC OFFICERSale7,500$150.96KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related